Form 4: Moderna CFO James Mock Reports Stock Transactions

James Mock, Moderna's Chief Financial Officer, reported the vesting and conversion of performance and restricted stock units into common stock, along with the withholding of shares to cover tax obligations.

Summary

• On February 27, 2025, James Mock, the Chief Financial Officer of Moderna, engaged in multiple transactions involving Moderna's common stock.
• These transactions included the conversion of performance stock units and restricted stock units into common stock.
• Shares were also withheld to satisfy tax obligations related to the vesting of these units.
• Specifically, 1,326 performance stock units were converted, resulting in the acquisition of 13,065 shares.
• Additionally, 3,094 and 1,326 restricted stock units were converted, resulting in the acquisition of 15,517 and 15,347 shares respectively.
• A total of 642 and 1,496 shares were withheld at a price of $33.58 to cover tax obligations related to the vesting of performance and restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral filing reflecting standard executive compensation practices. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders and their holdings in the company's stock. This filing is specific to Moderna and its CFO's transactions.

Stakeholder Impact

• The transactions reported may have a minor impact on the overall shareholding structure, but are unlikely to significantly affect stakeholders.

Key Dates